MyFinsight
Home
Blog
About
Cash and cash
equivalents
$1,006,702K
(1387.69%↑ Y/Y)
Short-term investments
$351,056K
(97.94%↑ Y/Y)
Accounts receivable, net
$67,011K
(62.30%↑ Y/Y)
Short-term portion of
financial royalty assets,...
$12,982K
(26.33%↑ Y/Y)
Inventory
$10,263K
(-33.74%↓ Y/Y)
Other current assets
$6,191K
(28.55%↑ Y/Y)
Income taxes
receivable
$2,911K
(251.57%↑ Y/Y)
Total current assets
$1,457,116K
(312.85%↑ Y/Y)
Intangible assets, net
$209,244K
(-16.35%↓ Y/Y)
Long-term portion of
financial royalty assets,...
$194,228K
(0.35%↑ Y/Y)
Other investments
$114,483K
(949.53%↑ Y/Y)
Goodwill
$101,541K
(0.00%↑ Y/Y)
Equity method
investments
$42,390K
Deferred income taxes,
net
$37,119K
(4377.56%↑ Y/Y)
Noncurrent derivative
assets
$17,913K
(-0.25%↓ Y/Y)
Other assets
$11,841K
(29.96%↑ Y/Y)
Total assets
$2,185,875K
(130.43%↑ Y/Y)
Total liabilities and
stockholders equity
$2,185,875K
(130.43%↑ Y/Y)
Total liabilities
$1,218,359K
(914.67%↑ Y/Y)
Total stockholders
equity
$967,516K
(16.78%↑ Y/Y)
Convertible senior notes,
net
$1,126,594K
Total current
liabilities
$46,736K
(-27.80%↓ Y/Y)
Deferred income taxes,
net
$21,654K
(-32.85%↓ Y/Y)
Other long-term
liabilities
$17,216K
(19.81%↑ Y/Y)
Long-term operating lease
liabilities
$3,777K
(-18.41%↓ Y/Y)
Long-term contingent
liabilities
$2,382K
(-41.86%↓ Y/Y)
Retained earnings
$583,251K
(26.41%↑ Y/Y)
Additional paid-in capital
$379,769K
(5.89%↑ Y/Y)
Accumulated other
comprehensive income
$4,476K
(-47.30%↓ Y/Y)
Common stock, 0.001 par
value 60,000 shares...
$20K
(0.00%↑ Y/Y)
Accrued liabilities
$31,867K
(82.47%↑ Y/Y)
Accounts payable
$9,405K
(9.56%↑ Y/Y)
Income taxes payable
$3,217K
(954.75%↑ Y/Y)
Current operating lease
liabilities
$1,082K
(-0.64%↓ Y/Y)
Other current
liabilities
$955K
Current contingent
liabilities
$210K
(-85.67%↓ Y/Y)
Back
Back
Balance Sheet
LIGAND PHARMACEUTICALS INC (LGNDZ)
LIGAND PHARMACEUTICALS INC (LGNDZ)
source: myfinsight.com